Jammu Hospitals Initiate Cancer Genetic Testing Using NGS Technology

Jammu Hospitals Initiate Cancer Genetic Testing Using NGS Technology

Asif Iqbal | March 6, 2024 | 07:44 PM IST | Health, Jammu, Jammu Kashmir | Follow on Google News

Jammu Hospitals Initiate Cancer Genetic Testing Using NGS Technology……image/daily excelsior

Jammu Hospitals Initiate Cancer Genetic Testing Using NGS Technology

In a groundbreaking initiative, the Department of Microbiology at Government Medical College and Hospital Jammu has ushered in a new era by initiating genetic testing for BRCA1 and BRCA2 mutations. Leveraging cutting-edge Next Generation Sequencing (NGS) technology, this move represents a significant stride towards advancing diagnostics and research capabilities.

Jammu Hospitals Initiate Cancer Genetic Testing:Empowering Precision Medicine through NGS Technology

Officials emphasize that this initiative is part of a broader strategy for capacity building in genetic sequencing. By embracing NGS technology, the department aims to provide the most advanced tools for diagnosing and researching genetic mutations associated with cancer, particularly targeting the BRCA1 and BRCA2 genes. These genes are notorious for harboring harmful mutations that significantly elevate the risk of breast cancer in affected individuals or their relatives.

DPAP Announces G M Saroori as Candidate for Udhampur-Doda Lok Sabha Seat

“Mutations in the BRCA1 or BRCA2 genes can escalate a woman’s risk of developing breast cancer to between 65-85 percent for BRCA1 mutations and 40-85 percent for BRCA2 by the age of 70,” underscores the significance of detecting these mutations early.

Jammu Hospitals Initiate Cancer Genetic Testing:Informed Choices for Women’s Health

Furthermore, officials highlight that receiving positive results for BRCA1 or BRCA2 mutations enables women to make informed choices well in advance. Armed with this knowledge, individuals can proactively explore available options that have the potential to mitigate their risk of developing breast cancer. This emphasis on early intervention and informed decision-making underscores the profound impact of genetic testing on women’s health.

Jammu Hospitals Initiate Cancer Genetic Testing:Expanding Horizons: Next Steps in NGS Testing

The Department of Microbiology is not resting on its laurels. In the second phase of implementation, officials reveal plans to integrate Human Papillomavirus (HPV) NGS testing. This expansion reflects the department’s commitment to continuously enhance its diagnostic capabilities, addressing a broader spectrum of genetic factors influencing health.

Jammu Hospitals Initiate Cancer Genetic Testing:Pioneering NGS in Government Healthcare

Under the visionary leadership of Principal and Dean, Dr. Ashutosh Gupta, the Department of Microbiology at GMC Jammu has achieved this milestone with commendable administrative support. With faculty and scientists adept in Bioinformatics and NGS technology, it proudly stands as the first government institution in Jammu and Kashmir to initiate NGS diagnostic testing in the healthcare sector. This accomplishment marks a significant stride towards integrating cutting-edge technologies into government healthcare practices, setting a precedent for future advancements in genetic testing.

Asif Iqbal

Asif Iqbal is a seasoned news writer with a passion for delivering the latest updates to the public. Currently serving as the senior writer at VoM News, a prominent news outlet known for its comprehensive coverage of diverse topics, Asif has established himself as a reliable source of information. With a keen eye for detail and a knack for storytelling, he consistently provides readers with well-crafted articles that cover a wide range of news categories. His dedication to journalistic integrity and his commitment to staying ahead of the news curve make him an invaluable asset to Vom News, ensuring that readers are always well-informed on the issues that matter most. You can find his work and stay updated on current events by visiting vomnews.in.